Green Line Apothecary is closing its pharmacy business. Here's what comes next for them.
CVS has acquired the pharmacy side of the business, which means that the popular soda fountains will be closing too.
CVS Health Path Forward Becomes Clearer And Breakup Is Unlikely
Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...
Business Insider11h
J.P. Morgan Reaffirms Their Buy Rating on CVS Health (CVS)
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers ...
Hosted on MSN1d
Estimates for CVS Southbound After Rocky Q3: How to Play the Stock
A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy ...
CVS names former UnitedHealth exec to run Aetna, shares jump
CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...
Buy, Sell, Or Hold CVS Stock?
CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant
CVS Health fell short on third-quarter profit, but it posted strong sales and shook up leadership under new CEO David Joyner ...
CVS Health Corp (CVS) Q3 2024 Earnings Call Highlights: Strong Retail Pharmacy Performance Amid ...
CVS Health Corp (CVS) reports robust growth in retail pharmacy and health services, while navigating challenges in its health ...
CVS Health: Buy Rating with Projected EPS Growth and Strategic Optimism Amid Retail Challenges
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...